OSE Immunotherapeutics SAEURONEXT: OSE

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026

· Issued by OSE Immunotherapeutics SA via Euronext

Filed with Euronext · · 2 pages · English

OSE Immunotherapeutics SA on 6ix

Earlier from OSE Immunotherapeutics

Later from OSE Immunotherapeutics

All OSE Immunotherapeutics news releases